At the news
? BULLISHIMPACT 5/10 CLUSTER filed Mar 10, 2026 at 20:00 ET
Two corporate insiders at Oncolytics Biotech purchased shares in the open market within the past week, including CEO Kelly Jared and Director James T. Parsons, signaling confidence in the company. The total value of purchases was $15,148, a small but notable insider buying cluster.
- CEO Kelly Jared purchased 5,050 shares at $0.96 per share for a total of $4,848 in open-market transactions.
- Director James T. Parsons purchased 10,000 shares at $1.03 per share for a total of $10,300 in open-market transactions.
- All transactions were open-market purchases (P), indicating actual cash investment by insiders.
- Total insider buying in the past 7 days: $15,148 across 2 transactions.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access